Cancer immunotherapy: a treatment for the masses
- PMID: 15247469
- DOI: 10.1126/science.1100369
Cancer immunotherapy: a treatment for the masses
Abstract
Cancer immunotherapy attempts to harness the exquisite power and specificity of the immune system for the treatment of malignancy. Although cancer cells are less immunogenic than pathogens, the immune system is clearly capable of recognizing and eliminating tumor cells. However, tumors frequently interfere with the development and function of immune responses. Thus, the challenge for immunotherapy is to use advances in cellular and molecular immunology to develop strategies that effectively and safely augment antitumor responses.
Similar articles
-
Cancer immunogene therapy.Arch Immunol Ther Exp (Warsz). 2001;49(5):337-43. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11798131 Review.
-
Tumor vaccine: current trends in antigen specific immunotherapy.Indian J Exp Biol. 2005 May;43(5):389-406. Indian J Exp Biol. 2005. PMID: 15900903 Review.
-
Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.Trends Immunol. 2008 May;29(5):242-9. doi: 10.1016/j.it.2008.02.002. Epub 2008 Mar 26. Trends Immunol. 2008. PMID: 18372215 Review.
-
Tumor immunity and immunotherapy.Hepatogastroenterology. 2001 Jul-Aug;48(40):1040-4. Hepatogastroenterology. 2001. PMID: 11490795 Review.
-
Cellular and humoral immune responses of cancer patients to defined tumor antigens.Cancer Chemother Biol Response Modif. 2001;19:385-93. Cancer Chemother Biol Response Modif. 2001. PMID: 11686025 Review. No abstract available.
Cited by
-
Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation.J Immunother. 2012 Jun;35(5):367-73. doi: 10.1097/CJI.0b013e3182562d76. J Immunother. 2012. PMID: 22576341 Free PMC article. Review.
-
From Biosensors to Robotics: Pioneering Advances in Breast Cancer Management.Sensors (Basel). 2024 Sep 23;24(18):6149. doi: 10.3390/s24186149. Sensors (Basel). 2024. PMID: 39338894 Free PMC article. Review.
-
Irradiation of donor mononuclear cells for treatment of chemorefractory metastatic solid cancers: a community-based immune transplant pilot study.Cancer Res Treat. 2012 Jun;44(2):133-41. doi: 10.4143/crt.2012.44.2.133. Epub 2012 Jun 30. Cancer Res Treat. 2012. PMID: 22802752 Free PMC article.
-
Designing therapeutic cancer vaccine trials with delayed treatment effect.Stat Med. 2017 Feb 20;36(4):592-605. doi: 10.1002/sim.7157. Epub 2016 Nov 2. Stat Med. 2017. PMID: 27807870 Free PMC article.
-
Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis.J Korean Med Sci. 2007 Sep;22 Suppl(Suppl):S38-46. doi: 10.3346/jkms.2007.22.S.S38. J Korean Med Sci. 2007. PMID: 17923753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources